Principio is a biotechnology company that develops and manufactures novel, proprietary molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer.

Principio’s proprietary technology allows for the imaging and treatment of cancer at previously unattainable levels of specificity and individualization.

Led by a management team with significant technology development and commercialization experience, we are targeting a large and expanding market that offers multiple revenue streams and strong projected profit margins. All of these elements create a unique opportunity for accelerated growth and significant potential return on investment.

Management Team

Scientific Advisory Board

Principio
15601 Crabbs Branch Way
Rockville, MD 20855
USA

301.526.5197 (phone)
301.738.0779 (fax)
info@principioinc.com